The Latest HCT Research
Easily stay up-to-date on the latest research advances in hematopoietic cell transplantation (HCT) that is saving lives. Find summaries and references for recent publications.
A free service providing you:
- Critical information early in disease course
- HLA typing for patients and family at diagnosis
Free education activities
Browse our new education catalog to access on-demand, live, and podcast activities on key topics including AML, MDS and SCD treatment.
Explore the activities most relevant to your practice by using filters, such as disease specific, clinical topics, and continuing education credits.
Partnering to Save Lives
In addition to operating the Be The Match Registry, we also facilitate 6,400 transplants each year, conduct research, and support patients and clinicians. Find out all we do to partner with you to save lives.
Disease-Specific Indications and Outcomes
Find the latest references, outcomes, and referral timing guidelines by disease. Access patient-friendly handouts.
Remove barriers to patient and family member HLA typing at diagnosis. Get the critical info you need to make treatment decisions.Discover How
Rapid donor identification improves survival in high-risk first-remission patients with Acute Myeloid Leukemia
Further investigation needed on the effect of cryopreserved allogeneic HCT outcomes
HCT provides a significant survival benefit for patients with MDS aged 50 to 75
National Marrow Donor Program®/Be The Match® and CIBMTR® (Center for International Blood and Marrow Transplant Research®) note studies of older adults with MDS demonstrate significant survival benefit
Why race matter in transplants cellular therapies
Understanding and meeting the psychosocial needs of sibling donors
About the Clinicians Section
This section of our health care professional website provides comprehensive information, research, and resources for health care professionals who care for patients before, during, and/or after hematopoietic cell transplant. The National Marrow Donor Program®(NMDP)/Be The Match® is a global leader in facilitating bone marrow and umbilical cord blood transplants to save the lives of patients with leukemia, lymphoma, genetic disorders, and other diseases, and conducts research through our research program, CIBMTR® (Center for International Blood and Marrow Transplant Research).
New clinician support in México
Since 2017, Be The Match® México
has been helping to save more lives through cellular therapy by improving donor
availability and removing barriers to transplant for patients of Latino
descent. Find out more about
how our subsidiary can help you facilitate transplants, conduct research, and provide
patient support in México.